The activation of the Keap1-Nrf2-ARE signaling pathway in neurodegenerative disease models has been shown to provide cellular antioxidant protection, reduce neuronal damage, and delay disease progression (Chakkittukandiyil et al., 2024). Here, NFE2L2 is linked to neurodegenerative disease.